Parvovirus B19 infection in Chile: Markers of infection and immunity in patients with clinical symptoms
Author
dc.contributor.author
Larrañaga, Carmen
Author
dc.contributor.author
León, Oscar
Author
dc.contributor.author
Díaz, Patricia
Author
dc.contributor.author
Miranda, Marta
Author
dc.contributor.author
Norambuena, Ximena
Author
dc.contributor.author
Pérez, Marcela
Author
dc.contributor.author
Gaggero Brillouet, Aldo
Admission date
dc.date.accessioned
2019-03-11T12:54:55Z
Available date
dc.date.available
2019-03-11T12:54:55Z
Publication date
dc.date.issued
2007
Cita de ítem
dc.identifier.citation
Journal of Medical Virology, Volumen 79, Issue 12, 2018, Pages 1927-1934
Identifier
dc.identifier.issn
01466615
Identifier
dc.identifier.issn
10969071
Identifier
dc.identifier.other
10.1002/jmv.21018
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/164411
Abstract
dc.description.abstract
Parvovirus B19 infection is associated with a wide variety of symptoms and signs, and given that some clinical features, such as anemia, arthropathy and rash may be attributable to other causes, laboratory diagnosis of B19 markers is necessary. The principal aims were to study the behavior of B19 infection-associated diseases in the Chilean population and to compare B19 markers for recent or active infection and for immunity status in patients with clinical symptoms suspicious of B19 infection and control individuals. Sera from a total of 267 patients with diverse clinical manifestations associated with B19 and from 69 healthy controls were tested for B19 DNA using PCR and for specific IgM and immunoglobulin G (IgG) by enzyme-linked immunosorbent assay (ELISA). Out of 267 patients examined, 89 had B19-associated disease markers: 43 had B19 DNA without IgM, 25 had IgM without B19 DNA, and 21 had both B19 DNA and IgM. Also 49 patients were positive only for IgG without B19 DNA or IgM. Ou